Chintan shivir on drugs to diagnose and treat issues of trust, quality

Proposals to be discussed at Hyderabad conclave include having a centralised drug registration system under CDSCO

In December last year, Finance Minister Nirmala Sitharaman hailed India as the “Pharmacy of the World”, owing to its high and efficient production of “global standard medicine” at affordable costs. However, that image suffered considerable damage following allegations of sub-standard or contaminated drugs exported to countries like Gambia and Uzbekistan.
 

To “ensure that the regulatory mechanisms of the country are of impeccable standards and are sustained over time and space”, the Centre has begun a series of chintan shivirs or thought meets with the country’s top drug regulators, senior government policy officials, industry representatives, and stakeholders to deliberate on pathways